Currently Viewing:
ISPOR 2018
Dr Harlan Krumholz Outlines the Impact of New Technology and Innovations on Healthcare Delivery
May 21, 2018
Value Assessments Are Just One Tool in the Decision-Maker's Toolkit, Panel Says
May 21, 2018
Transforming Healthcare: Boosting Real-World Evidence With Digital Health
May 21, 2018
Sally Okun: It's Time to Empower the Health Data Being Collected
May 21, 2018
Dr Clifford Goodman Discusses the Challenge of Valuing New, Expensive Therapies for Rare Diseases
May 22, 2018
All-Cause Healthcare Payments Substantial for Younger Adults With Depression, and Other Poster Findings at ISPOR
May 22, 2018
Personalizing the Digital Data Revolution in Healthcare
May 22, 2018
Dr Adrian Hernandez Highlights the Use of Real-World Evidence and Current Barriers
May 22, 2018
Panelists Give Payer, Patient, and Economist Perspectives on High-Cost Drugs for Rare Diseases
May 23, 2018
Dr Steven Pearson Highlights the Challenge of Evaluating New Interventions That Cure Diseases
May 23, 2018
Dr Ejim Mark: Digital Health Runs the Risk of Exacerbating Disparities
May 23, 2018
Value Assessments in the Age of Personalized Medicine May Require a Cultural Shift, Panel Says
May 23, 2018
Valuation Challenges and Ethical Implications of Cures
May 23, 2018
Sally Okun: Using Digital Health Improvements to Include the Patient Voice in Healthcare
June 14, 2018
Currently Reading
Dr Harlan Krumholz on Using New Technologies, Data Generation to Prevent or Address Epidemics
June 18, 2018
Sally Okun Outlines What Patients Define as Good Care
June 26, 2018
Dr Ejim Mark: Challenges With and Protecting the Increasing Amount of Health Data
June 27, 2018
Dr Harlan Krumholz: How Healthcare Can Better Implement New Technologies
June 29, 2018
Dr Adrian F. Hernandez: Mapping Human Health Through Project Baseline
July 03, 2018
Sally Okun on How Informed Patients Feel When Starting Treatment After a New Diagnosis
July 09, 2018
Dr Clifford Goodman on Progress With the Move to Value-Based Payments
July 09, 2018
Dr Clifford Goodman Discusses How Healthcare Should Address Social Determinants of Health
July 20, 2018
Dr Harlan Krumholz on Barriers Preventing Healthcare From Using Data to Improve Care
August 01, 2018

Dr Harlan Krumholz on Using New Technologies, Data Generation to Prevent or Address Epidemics

If we’ve got data moving, and if we’re analyzing it in smart ways in real time, we should be able to detect problems within our healthcare system much more rapidly than we have been able to in the past, explained Harlan Krumholz, MD, SM, the Harold H. Hines Jr professor, Medicine and Epidemiology and Public Health, Yale School of Medicine, and director, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.


This page contains sponsored advertising.

If we’ve got data moving, and if we’re analyzing it in smart ways in real time, we should be able to detect problems within our healthcare system much more rapidly than we have been able to in the past, explained Harlan Krumholz, MD, SM, the Harold H. Hines Jr professor, Medicine and Epidemiology and Public Health, Yale School of Medicine, and director, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.

Transcript

How can new technologies or better data generation prevent or address epidemics, like the current opioid epidemic?

It we’ve got data moving, and if we’re analyzing it in smart ways in real time, we should be able to detect problems within our healthcare system much more rapidly than we have been able to in the past. Things like the opioid epidemic shouldn’t have been by chance. Enough evidence accumulates, and all of a sudden it becomes a national priority. We should be able to understand this early; we should be able to see what costs are being accrued, what suffering is associated with it, how people are being burdened by it, and how prescriptions are going up. We should have a dashboard and dashboards that help us understand what’s moving and what’s not, and that’s true in noncommunicable disease problems, behavioral problems, and infectious problems. We should be tracking this all the time.

An example of this is readmissions. We implement a policy, but the truth is we can only really track readmissions about a year later, so we can’t be agile, we can’t tweak the policies, and we can’t understand where we’re going wrong, because we’re not getting data back fast enough. We need to be able to have a picture of the entire healthcare system. It needs to be streaming in ways that inform us, and help us be able to target interventions, and then, honestly, within the healthcare systems, we need to be doing A/B testing just like software developers do. We need to try different things, get results, understand what they do, and be able to continue to iterate them over time, so that we can improve. Without that, we’re stuck in a situation where we may make change, a year later we find out what that change did, and it may take us another year to make another change. We’re moving way too slow, and we’ll never learn that way. So, we both have to be able to detect problems, address them, understand what our interventions are doing, and be able to rapidly iterate if we want to be a true learning healthcare system.   

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up